S&P Futures
4,291.75 -6.50 (-0.15%) Dow Futures
33,855.00 -18.00 (-0.05%) Nasdaq Futures
13,659.00 -22.25 (-0.16%) Russell 2000 Futures
2,022.30 -1.50 (-0.07%) Crude Oil
88.71 -0.70 (-0.78%) Gold
1,796.00 -2.10 (-0.12%)
G Medical Innovations Holdings Ltd (GMVD)
After hours:
Chart Events
Performance Outlook
| Previous Close | 0.3906 |
| Open | 0.3970 |
| Bid | 0.0000 x 1000 |
| Ask | 0.0000 x 800 |
| Day's Range | 0.3774 - 0.3970 |
| 52 Week Range | 0.3200 - 6.7400 |
| Volume | |
| Avg. Volume | 2,822,561 |
| Market Cap | 5.196M |
| Beta (5Y Monthly) | -1.10 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.9160 |
| Earnings Date | Sep 15, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire
G Medical Innovations is introducing affordable, new direct to consumer home health testing kits with quick results
The first 7 new health testing kits covering Food sensitivity (96 and 208 types of food), indoor/outdoor allergies, Thyroid functioning, testosterone levels, HbA1C and HPV tests will be available for purchasing by consumers during Q3-2022 online as well as at popular retail locations and pharmacies The tests offered to the consumers utilize FDA registered componentsTest kit prices range from $50-$260, all provide results within days by CLIA certified labsAdditional testing kits to be announced l
- GlobeNewswire
G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) Announces Receipt of Nasdaq Minimum Bid Price Notification
Irvine, California, June 17, 2022 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (the “Company”), a telehealth, medical device, and remote patient monitoring company providing clinical-grade solutions for consumers, medical professionals, and healthcare institutions, has received a written notice (the “Notice”) from Nasdaq Stock Market LLC, indicating that the Company is not in compliance with the minimum bid price requirement for continued listing set forth in Nasdaq Lis
- GlobeNewswire
G Medical Innovations Holdings Ltd. (NASDAQ: GMVD) Announces Share Repurchase Program
Irvine, California, May 20, 2022 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (NASDAQ: GMVD) (the “Company”) today announced that its board of directors has authorized a share repurchase program to acquire up to $1 million of the Company's ordinary shares (the “Repurchase Plan”). The Company may purchase ordinary shares from time to time in the open market, through privately negotiated transactions, or any other legally permissible ways, depending on market conditions, share price, tr
